East/West CEO Conference to Feature Prominent CEOs and Other Industry Leaders on January 10th and 11th

Share Article

Boston Biotech Conferences Invites You to Join John Lechleiter (Eli Lilly), Sue Desmond-Hellmann (Bill & Melinda Gates Foundation), Bob Duggan (Pharmacyclics), Michael Hayden (Teva), Francois Nader (NPS Pharmaceuticals), Stephen Oesterle (Medtronic), John Reed (Roche), Elias Zerhouni (Sanofi) in San Francisco for a 2-day, high-level, high-energy networking event.

“If you are going to be at JP Morgan in January, this is the must-attend event for the biotech industry. These meetings are simply the best for efficient, high-level knowledge and networking.“ - Jonathan Lewis, CEO of Ziopharm Oncology

Leading CEOs from the New York, Boston, California, Europe and Asia biotechnology communities will gather at the 2015 East/West CEO Conference on January 10th and 11th at The Four Seasons Hotel San Francisco.

The East/West CEO Conference is an off-the-record forum for industry CEOs and decision makers in life sciences. The conference agenda features luminaries in medicine and research, as well as executives of the next generation of leading biotechnology and pharmaceutical companies, who will explore the most relevant issues facing our industry today. Panel topics include Funding Innovation While Balancing Risk, Global Entrepreneurs: Building Biotechs Ex-US, Healthcare Market Outlook: Predictions for 2015, New Trends in Oncology, Building A Biotech: Innovative Business Models, IPOs: 2015 Predictions and more.

“As a gateway to the 33rd JP Morgan Healthcare extravaganza, the East/West Conference provides an ideal and intimate setting for CEOs and other senior officers of a wide range of biopharmaceutical companies to share thoughts and debate strategy,” says Mathai Mammen, MD, PhD, Founder and Senior Vice President of R&D at Theravance Biopharma. “The stunningly wide range of approaches, some orthogonal to one another, taken by numerous smart teams that navigate a pathway to impactful medicines and shareholder value will make for a stimulating weekend.”

Jonathan Lewis, CEO of Ziopharm Oncology, adds: “If you are going to be at JP Morgan in January, this is the must-attend event for the biotech industry. These meetings are simply the best for efficient, high-level knowledge and networking.“

Conference speakers include: Marc Casper (Thermo Fisher Scientific), Doug Giordano (Pfizer), Greg Lucier (formerly of Life Technologies), David Pyott (Allergan), Paul Stoffels (Johnson & Johnson), Meg Tirrell (CNBC) and many more prominent industry leaders.

For more information and to register for the conference, click here.

ABOUT BOSTON BIOTECH CONFERENCES

The Boston Biotech Conferences (BBC)’s mission is to build a vibrant community of biopharma leaders, which will help to drive innovation in biotech, and bring important drugs to patients more quickly. The conferences are exclusive, thought-leader forums for senior bio-pharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the bio-pharma community. The meetings are invitation-only, off-the-record forums that bring together the past, present and future leaders in the healthcare community to network, exchange ideas and share insights into the industry's challenges and opportunities.

For more information on BBC, please visit: http://www.bbbiotechconference.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cristina Ojeda
@BiotechConf
Follow >
Boston Biotech Conferences
since: 05/2012
Like >
Visit website